Loading...
Market
What will be the impact of Sierra Leone's Ebola vaccination campaign on regional health collaborations by December 2025?
2
Resolution / Starting Odds
Strengthened collaborations • 25%
No significant change • 25%
Weakened collaborations • 25%
Other outcomes • 25%
Reports from regional health organizations or international health agencies
Story
Sierra Leone Launches Nationwide Preventive Ebola Vaccination Campaign in December 2024
Dec 5, 2024, 12:14 PM
Sierra Leone has launched its first nationwide preventive Ebola vaccination campaign in December 2024, marking a significant step in rebuilding its healthcare system a decade after the devastating Ebola outbreak. The nationwide rollout aims to prevent future outbreaks of the virus, which claimed thousands of lives during the 2014-2016 epidemic. The initiative is part of the country's broader efforts to strengthen public health infrastructure and improve resilience against infectious diseases.
View original story
Similar markets
Successful containment • 25%
Partial containment • 25%
No containment • 25%
Worsening outbreak • 25%
Significant decrease in cases • 25%
Moderate decrease in cases • 25%
No change in case numbers • 25%
Increase in cases • 25%
Successful • 25%
Partially Successful • 25%
Unsuccessful • 25%
No Results Released • 25%
Highly Effective (>90% reduction) • 25%
Moderately Effective (50-90% reduction) • 25%
Slightly Effective (10-50% reduction) • 25%
Not Effective (<10% reduction) • 25%
Increased funding • 25%
New global task force • 25%
Revised treatment guidelines • 25%
Other • 25%
Significant reduction in cases • 25%
Moderate reduction in cases • 25%
No significant impact • 25%
Increase in cases • 25%
Significant improvement • 25%
Moderate improvement • 25%
Little to no improvement • 25%
Negative impact • 25%
Widespread policy changes • 25%
Limited policy changes • 25%
No policy changes • 25%
Other outcomes • 25%
Significant reduction in mpox cases • 25%
Moderate reduction in mpox cases • 25%
No significant change in mpox cases • 25%
Increase in mpox cases • 25%
Africa • 25%
South America • 25%
Asia • 25%
Other • 25%
Yes • 50%
No • 50%
Outbreak fully controlled • 25%
Outbreak partially controlled • 25%
Outbreak ongoing • 25%
Outbreak worsened • 25%